Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 392, pseudogene (RN7SL392P)

Target
RN7SL392P
Molecular classification
Pseudogene, Non-coding RNA–derived pseudogene
01

Overview

RN7SL392P represents a pseudogene—an inactive, non-protein-coding DNA sequence—that is highly homologous to the functional 7SL RNA gene family, which encodes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein essential for targeting secretory proteins to the endoplasmic reticulum in eukaryotic cells[1][3][6]. RN7SL392P, like nearly all RN7SL pseudogenes, is thought to arise from the reverse transcription and reintegration of 7SL RNA transcripts into the genome, often resulting in truncated, nonfunctional copies lacking the regulatory or coding features of the parent gene[6][7]. There is no evidence of transcription or protein-coding function for RN7SL392P itself, nor is it implicated directly as a therapeutic target, disease biomarker, or mechanism of drug action. Its existence, like that of other pseudogenes, may reflect the evolutionary history of the 7SL/SRP family rather than any direct physiological role.

Other names
RN7SL392PRNA, 7SL, cytoplasmic 392, pseudogene
02

Biological functions

None established for this specific pseudogeneAs a class, some pseudogenes may have regulatory roles (e.g. acting as microRNA decoys or sources of small RNAs), but there is no evidence this is true for RN7SL392P specifically
03

Disease associations

No direct disease association for RN7SL392PThe broader 7SL RNA family, and some RN7SL pseudogenes, have been implicated in cancer and cell stress responses, but not this specific pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 392, pseudogene (RN7SL392P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 392, pseudogene (RN7SL392P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call